$254MSeries B, 14 October 2025
Advance three late-stage programs: dilated cardiomyopathy, aortic valve stenosis and acute severe hypertension
- Amount
- $254M
- Stage
- Series B
- Announced
- 14 October 2025
- Lead
- Fidelity Management & Research
- Other investors
- T. Rowe Price, ARCH Venture Partners, Sequoia Heritage
- Use of funds
- Advance three late-stage programs: dilated cardiomyopathy, aortic valve stenosis and acute severe hypertension
- Checked
- Announced by the company
- Sources
- Kardigan raises $254M Series B (date approx) vcaonline.com
Kardigan raises $254M Series B (date approx) tryfundable.ai